LINDA FORD: Open Payments
NPI 1689116964 · JENA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$952 in 39 payments from 13 companies in 2025. Trend: 2023 $522 · 2024 $531 · 2025 $952
Food & beverage: $952
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 16 | $430 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $226 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $83 |
| Otsuka America Pharmaceutical, Inc. | 3 | $44 |
| Lilly USA, LLC | 2 | $28 |
| Neurelis, Inc. | 1 | $27 |
| Alkermes, Inc. | 1 | $22 |
| Amgen Inc. | 1 | $17 |
| Lundbeck LLC | 1 | $16 |
| Exact Sciences Corporation | 1 | $16 |
Products named: Auvelity, CAPLYTA, JARDIANCE, REXULTI, VALTOCO, ARISTADA, OTEZLA, Cologuard Collection Kit.
Industry payments across LA — which companies pay providers there.
